Detection of latent tuberculosis infection in rheumatologic diseases before anti-TNFα therapy: Tuberculin skin test versus IFN-γ assay

Rheumatology International

Volumn 32, Issue 11, 2012, Pages 3599-3603

  Hanta, Ismail ^a   Ozbek, Suleyman ^a   Kuleci, Sedat ^a   Seydaoglu, Gulsah ^a   Ozyilmaz, Ezgi ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Interferon gamma assays; Latent tuberculosis; Rheumatologic diseases; Tuberculin skin test

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; BCG VACCINATION; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUBERCULIN TEST;

ADULT; FEMALE; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; RHEUMATIC DISEASES; TUBERCULIN TEST;

EID: 84872186957     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2243-x     Document Type: Article

References (22)

1. Keane J (2005) TNF-blocking agents and tuberculosis: new drugs illuminate and old topic. Rheumatology 44:714-720
2. Ellerin T, Rubin RH, Weinblatt ME (2003) Infections and anti tumor necrosis factor a therapy. Arthritis Rheum 48:3013-3022
3. Kroesen S, Widmer AF, Tyndall A, Hasler P (2003) Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy. Rheumatology (Oxford) 42:617-621
4. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098-1104
5. Gomez Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: amulticenter active-surveillance report. Arthritis Rheum 48:2122-2127
6. Gardam MA, Keystone EC, Menzies R et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148-155
7. British Thoracic Society Standards of Care Commitee (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. Thorax 60:800-805
8. Huebner RE, Schein MF, Bass JB (1993) The tuberculin skin test. Clin Infect Dis 17:968-975
9. Pai M, Riley LW, Colford JM (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4:761-776
10. Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R, Pastor C, Harrison J, Sánchez-Schwartz C (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360-1361
11. Barnes PF (2001) Diagnosing latent tuberculosis infection: the 100 year upgrade. Am J Respir Crit Care Med 163:807-808
12. Anderson P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356:1099-1104
13. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW, Colford JM Jr. (2005) Mycobacterium tuberculosis infection in health care workers in rural India comparison of a whole-blood interferon-gamma assay with tuberculin skin testing. JAMA 293:2746-2755
14. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I (2004) Specific detection of tuberculosis infection: an interferongamma based assay using new antigens. Am J Respir Crit Care Med 170:59-64
15. Brock I, Weldingh K, Lillebaek T, Follman F, Andersen P (2004) Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170:65-69
16. Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK, Pogoda JM, Ewer K, Barnes PF (2005) Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 172:1161-1168
17. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361:1168-1173
18. Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X, RATIO (Research Axed on Tolerance of Biotherapies) Study Group (2007) Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis 66:1610-1615
19. Matulis G, Jüni P, Villiger PM, Gadola SD (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases-performance of a mycobacterium tuberculosis antigen specific IFN-gamma assay. Ann Rheum Dis 67:84-90
20. Smith R, Cattamanchi A, Steingart KR, Denkinger C, Dheda K, Winthrop KL, Pai M (2011) Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immunemediated inflammatory disorders. Curr Opin Rheumatol 23:377-384
21. Denkinger CM, Dheda K, Pai M (2011) Guidelines on interferonc release assays for tuberculosis infection: concordance, discordance or confusion?. Clin Microbiol Infect 17:806-814
22. Piana F, Codecasa LR, Besozzi G, Migliori GB, Cirillo DM (2005) Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis. Am J Respir Crit Care Med 172:631-635